简介:
Overview
This protocol outlines the use of ultra-high-frequency ultrasound imaging combined with 3D rendering to monitor inguinal lymph node volume in a mouse model of metastatic melanoma. This non-invasive method allows for repeated imaging sessions, making it suitable for evaluating pharmacological treatments over time.
Key Study Components
Area of Science
- Oncology
- Imaging Techniques
- Preclinical Models
Background
- Melanoma is an aggressive cancer that metastasizes rapidly.
- Monitoring lymph node involvement is crucial for assessing disease progression.
- Current methods may not allow for repeated assessments in the same animal.
- Ultra-high-frequency ultrasound provides a non-invasive imaging option.
Purpose of Study
- To develop a method for monitoring lymph node volume in metastatic melanoma.
- To assess the impact of pharmacological treatments on metastatic disease.
- To demonstrate the feasibility of repeated imaging sessions in a preclinical model.
Methods Used
- Application of ultra-high-frequency ultrasound imaging.
- 3D rendering of lymph node volume.
- Use of the Braf/Pten mouse model for melanoma.
- Administration of 4-hydroxytamoxifen for melanoma induction.
Main Results
- Successful monitoring of lymph node volume increase over time.
- Method demonstrated to be well-tolerated by experimental animals.
- Potential for adaptation to various preclinical models of metastatic cancer.
- Facilitates assessment of drug efficacy in treating metastatic disease.
Conclusions
- The method provides a reliable way to monitor lymph node involvement in melanoma.
- It allows for multiple imaging sessions, enhancing experimental flexibility.
- This approach can be applied to evaluate different therapeutic strategies in cancer research.
What is the significance of monitoring lymph nodes in melanoma?
Monitoring lymph nodes helps assess the extent of metastasis and the effectiveness of treatments.
How does the ultrasound imaging method work?
It uses high-frequency sound waves to create detailed images of lymph node volume.
Can this method be used for other types of cancer?
Yes, it can be adapted for various preclinical mouse models of metastatic cancer.
What are the advantages of this imaging technique?
It is non-invasive, well-tolerated, and allows for repeated assessments.
Who conducted the study?
The study was conducted by Dr. Marianna Vitiello and Dr. Claudia Kusmic.
What is the role of 4-hydroxytamoxifen in this protocol?
It is used to induce melanoma in the mouse model for the study.